MeSH Review:
Behcet Syndrome
- A controlled trial of azathioprine in Behçet's syndrome. Yazici, H., Pazarli, H., Barnes, C.G., Tüzün, Y., Ozyazgan, Y., Silman, A., Serdaroğlu, S., Oğuz, V., Yurdakul, S., Lovatt, G.E. N. Engl. J. Med. (1990)
- Treatment of Bechçet's syndrome with transfer factor. Wolf, R.E., Fudenberg, H.H., Welch, T.M., Spitler, L.E., Ziff, M. JAMA (1977)
- Generalized myositis in Behçet disease: treatment with cyclosporine. Lingenfelser, T., Duerk, H., Stevens, A., Grossmann, T., Knorr, M., Saal, J.G. Ann. Intern. Med. (1992)
- Thalidomide effects in Behçet's syndrome and pustular vasculitis. Jorizzo, J.L., Schmalstieg, F.C., Solomon, A.R., Cavallo, T., Taylor, R.S., Rudloff, H.B., Schmalstieg, E.J., Daniels, J.C. Arch. Intern. Med. (1986)
- Thalidomide: current and potential clinical applications. Calabrese, L., Fleischer, A.B. Am. J. Med. (2000)
- Behçet disease and the emergence of thalidomide. Ehrlich, G.E. Ann. Intern. Med. (1998)
- Treatment of Behçet disease with pentoxifylline. Wolchok, J.D. Ann. Intern. Med. (1997)
- Acyclovir and Behçet's syndrome. Resegotti, L., Pistone, M. Ann. Intern. Med. (1984)
- Treatment of Behcet's syndrome with levamisole. de Merieux, P., Spitler, L.E., Paulus, H.E. Arthritis Rheum. (1981)
- Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. Chambers, J.C., Haskard, D.O., Kooner, J.S. J. Am. Coll. Cardiol. (2001)
- Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody. Travis, S.P., Czajkowski, M., McGovern, D.P., Watson, R.G., Bell, A.L. Gut (2001)
- Concentrations of sialic acid in serum in Behçet disease. Onat, T., Eğilmez, N., Cimrin, A. Clin. Chem. (1990)
- Determination of trace elements in blood serum of patients with Behçet disease by total reflection x-ray fluorescence analysis. Dogan, P., Dogan, M., Klockenkämper, R. Clin. Chem. (1993)
- The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Ota, M., Mizuki, N., Katsuyama, Y., Tamiya, G., Shiina, T., Oka, A., Ando, H., Kimura, M., Goto, K., Ohno, S., Inoko, H. Am. J. Hum. Genet. (1999)
- New variations of human CC-chemokine receptors CCR3 and CCR4. Kato, H., Tsuchiya, N., Izumi, S., Miyamasu, M., Nakajima, T., Kawasaki, H., Hirai, K., Tokunaga, K. Genes Immun. (1999)
- The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes. Lehner, T., Welsh, K.I., Batchelor, J.R. Immunology (1982)
- Current concepts in the etiology and treatment of Behçet disease. Evereklioglu, C. Survey of ophthalmology. (2005)
- Oxidative burst response to monosodium urate crystals in patients with Behçet's syndrome. Gogus, F., Fresko, I., Elbir, Y., Eksioglu-Demiralp, E., Direskeneli, H. Clin. Exp. Rheumatol. (2005)
- Life threatening chylous pleural and pericardial effusion in a patient with Behçet's syndrome. Cöplü, L., Emrí, S., Selçuk, Z.T., Kalyoncu, F., Balkanci, F., Sahín, A.A., Bariş, Y.I. Thorax (1992)
- Immunopathologic study of the conjunctiva in patients with behçet disease. Tugal-Tutkun, I., Urgancioglu, M., Foster, C.S. Ophthalmology (1995)
- Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Kotake, S., Higashi, K., Yoshikawa, K., Sasamoto, Y., Okamoto, T., Matsuda, H. Ophthalmology (1999)
- 2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Hylton, W., Cayley, J., Dore, C., Denman, A.M. Ann. Rheum. Dis. (1986)
- Neutrophil function studies in clinical medicine. Matzner, Y. Transfusion medicine reviews. (1987)
- Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease. Ozoran, K., Dügün, N., Gürler, A., Tutkak, H., Tokgöz, G. Scand. J. Rheumatol. (1995)
- Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome. Cekmen, M., Evereklioglu, C., Er, H., Inalöz, H.S., Doganay, S., Türköz, Y., Ozerol, I.H. International journal of dermatology. (2003)
- Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Bacon, T.H., Ozbakir, F., Elms, C.A., Denman, A.M. Clin. Exp. Immunol. (1984)
- Thalidomide: rationale for renewed use in immunological disorders. Schuler, U., Ehninger, G. Drug safety : an international journal of medical toxicology and drug experience. (1995)
- Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behcet disease. Rossi, G., Moretta, A., Locatelli, F. Blood (2004)
- Response to intradermal injection of monosodium urate crystals in Behçet's syndrome. Cakir, N., Yazici, H., Chamberlain, M.A., Barnes, C.G., Yurdakul, S., Atasoy, S., Akcasu, A., Iscimen, A. Ann. Rheum. Dis. (1991)
- Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Chan, C.C., Palestine, A.G., Nussenblatt, R.B., Roberge, F.G., Benezra, D. Ophthalmology (1985)
- Acute phase proteins and C9 in patients with Behcet's syndrome and aphthous ulcers. Adinolfi, M., Lehner, T. Clin. Exp. Immunol. (1976)
- Internal carotid artery dissection in a patient with Behçet's syndrome. Pannone, A., Lucchetti, G., Stazi, G., Corvi, F., Ferguson, T.L., Massucci, M., Zaccaria, A. Annals of vascular surgery. (1998)